Published online before print May 27, 2004, doi: 10.1161/01.STR.0000130988.44824.29
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:1697.)
© 2004 American Heart Association, Inc.
Original Contributions |
Longitudinal Risk of Intracranial Hemorrhage in Patients With Arteriovenous Malformation of the Brain Within a Defined Population
From the Departments of Anesthesia and Perioperative Care (A.X.H., J.P.B., A.S.A., W.L.Y.), the Center for Cerebrovascular Research (A.X.H., J.P.B., A.S.A., W.L.Y.), the Departments of Neurology (S.C.J., V.S., W.L.Y.), Epidemiology and Biostatistics (S.C.J., C.E.M.), and Neurological Surgery (W.L.Y.), University of California, San Francisco, Calif.; and the Division of Research (S.S.), Kaiser Permanente Medical Care Program, Oakland, Calif.
Correspondence to Dr William L. Young, University of California San Francisco, 1001 Potrero Avenue, Rm.3C-38, San Francisco, CA 94110. E-mail ccr{at}anesthesia.ucsf.edu
Background and Purpose— Accurate estimates for risk and rates of intracranial hemorrhage (ICH) in the natural course of patients harboring brain arteriovenous malformation (BAVM) are needed to provide a quantitative basis for planning clinical trials to evaluate interventional strategies and to help guide practice management.
Methods— We identified patients with BAVM at the Kaiser Permanente Northern California health maintenance organization and documented their clinical course. The influences of age at diagnosis, gender, race-ethnicity, ICH at presentation, venous draining pattern, and BAVM size on ICH subsequent to presentation were studied using the multivariate Cox proportional hazards model and Kaplan-Meier curves.
Results— We identified 790 patients with BAVM (51% female; 63% white; mean age±SD at diagnosis: 38±19 years) between 1961 and 2001. Patients who presented with ICH experienced a higher rate of subsequent ICH than those who presented without ICH under multivariate analysis (hazard ratio, 3.6; 95% CI, 1.1 to 11.9; P<0.032). The effect was similar across race-ethnicity and gender. This difference in ICH rates was greatest in the first year (7% versus 3% per year) and converged over time. The effect of subsequent ICH on functional status was similar to that of the initial ICH.
Conclusions— Presentation with ICH was the most important predictor of future ICH, confirming previous studies. Future ICH had similar impact on functional outcome as incident ICH. Intervention to prevent ICH would be of potentially greater benefit to patients presenting with ICH, although the advantage decreases over time.
Key Words: cerebral hemorrhage • vascular malformations • epidemiology
This article has been cited by other articles:
 |
|
 |
|
  C. Stapf and J.P. Mohr Unruptured Brain Arteriovenous Malformations Should Be Treated Conservatively: Yes Stroke, December 1, 2007; 38(12): 3308 - 3309. [Full Text] [PDF]
|
|
|
|
|
|
H. Kim, S. Sidney, C. E. McCulloch, K. Y. T. Poon, V. Singh, S. C. Johnston, N. U. Ko, A. S. Achrol, M. T. Lawton, R. T. Higashida, et al. Racial/Ethnic Differences in Longitudinal Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients Stroke, September 1, 2007; 38(9): 2430 - 2437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Khaw When Race/Ethnicity Matters More Than Size Stroke, September 1, 2007; 38(9): 2405 - 2406. [Full Text] [PDF]
|
|
|
|
|
|
M. V. Jayaraman, M. L. Marcellus, H. M. Do, S. D. Chang, J. K. Rosenberg, G. K. Steinberg, and M. P. Marks Hemorrhage Rate in Patients With Spetzler-Martin Grades IV and V Arteriovenous Malformations: Is Treatment Justified? Stroke, February 1, 2007; 38(2): 325 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stapf, H. Mast, R. R. Sciacca, J. H. Choi, A. V. Khaw, E. S. Connolly, J. Pile-Spellman, and J. P. Mohr Predictors of hemorrhage in patients with untreated brain arteriovenous malformation Neurology, May 9, 2006; 66(9): 1350 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Choi, H. Mast, R. R. Sciacca, A. Hartmann, A. V. Khaw, J. P. Mohr, R. L. Sacco, and C. Stapf Clinical Outcome After First and Recurrent Hemorrhage in Patients With Untreated Brain Arteriovenous Malformation Stroke, May 1, 2006; 37(5): 1243 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Achrol, L. Pawlikowska, C. E. McCulloch, K. Y. T. Poon, C. Ha, J. G. Zaroff, S. C. Johnston, C. Lee, M. T. Lawton, S. Sidney, et al. Tumor Necrosis Factor-{alpha}-238G>A Promoter Polymorphism Is Associated With Increased Risk of New Hemorrhage in the Natural Course of Patients With Brain Arteriovenous Malformations Stroke, January 1, 2006; 37(1): 231 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Al-Shahi and C Warlow Arteriovenous malformations of the brain: ready to randomise? J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1327 - 1329. [Full Text] [PDF]
|
|
|
|
|
|
J.P. Mohr Brain Arteriovenous Malformations: Children and Adults Stroke, October 1, 2005; 36(10): 2060 - 2061. [Full Text] [PDF]
|
|
|
|
|
|
H. J. Fullerton, A. S. Achrol, S. C. Johnston, C. E. McCulloch, R. T. Higashida, M. T. Lawton, S. Sidney, W. L. Young, and For the UCSF BAVM Study Project Long-Term Hemorrhage Risk in Children Versus Adults With Brain Arteriovenous Malformations Stroke, October 1, 2005; 36(10): 2099 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Young and G.-Y. Yang Are There Genetic Influences on Sporadic Brain Arteriovenous Malformations? Stroke, November 1, 2004; 35(11_suppl_1): 2740 - 2745. [Abstract] [Full Text] [PDF]
|
|